Cancer medicines
Sunitinib
Sunitinib
A multikinase inhibitor for selected kidney cancers, GIST and pancreatic neuroendocrine tumors.
Sources checked · Introductory guide
On this page
How it works
It inhibits signaling through targets including VEGFR, PDGFR and KIT.[3]
Where it is used
Used in kidney cancer, GIST after imatinib or intolerance, and selected pancreatic neuroendocrine tumors, distinct from pancreatic adenocarcinoma.[1]
Key safety points
Serious liver injury makes liver tests important. Report jaundice, dark urine, chest pain or bleeding immediately; discuss blood pressure and hand-foot symptoms.[2]
Questions for your care team
- What dosing or break schedule and liver, heart, blood pressure and skin monitoring are planned?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
- NCI · Sunitinib Malate (opens in a new tab)
- MedlinePlus · Sunitinib Malate (opens in a new tab)
- NCI Drug Dictionary · Sunitinib Malate (opens in a new tab)
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.